Discover the most talked about and latest scientific content & concepts.

YO Ali, HM Allen, L Yu, D Li-Kroeger, D Bakhshizadehmahmoudi, A Hatcher, C McCabe, J Xu, N Bjorklund, G Taglialatela, DA Bennett, PL De Jager, JM Shulman, HJ Bellen and HC Lu
Nicotinamide mononucleotide adenylyl transferase 2 (NMNAT2) is neuroprotective in numerous preclinical models of neurodegeneration. Here, we show that brain nmnat2 mRNA levels correlate positively with global cognitive function and negatively with AD pathology. In AD brains, NMNAT2 mRNA and protein levels are reduced. NMNAT2 shifts its solubility and colocalizes with aggregated Tau in AD brains, similar to chaperones, which aid in the clearance or refolding of misfolded proteins. Investigating the mechanism of this observation, we discover a novel chaperone function of NMNAT2, independent from its enzymatic activity. NMNAT2 complexes with heat shock protein 90 (HSP90) to refold aggregated protein substrates. NMNAT2’s refoldase activity requires a unique C-terminal ATP site, activated in the presence of HSP90. Furthermore, deleting NMNAT2 function increases the vulnerability of cortical neurons to proteotoxic stress and excitotoxicity. Interestingly, NMNAT2 acts as a chaperone to reduce proteotoxic stress, while its enzymatic activity protects neurons from excitotoxicity. Taken together, our data indicate that NMNAT2 exerts its chaperone or enzymatic function in a context-dependent manner to maintain neuronal health.
Facebook likes*
News coverage*
SC clicks
Hsp90, Proteins, Brain, Chaperone, Enzyme, Protein folding, Protein, Heat shock protein
MeSH headings
comments powered by Disqus

* Data courtesy of